Challenge Programme — Heat and Hypertension
Supports large Danish research teams studying heat stress impacts on hypertension outcomes.
The Novo Nordisk Foundation's Challenge Programme 2027 — Heat and Hypertension theme funds large interdisciplinary research consortia to investigate the mechanisms by which extreme heat events worsen health outcomes in hypertensive patients. This call addresses a recognised public health gap: as heatwave frequency increases alongside the global prevalence of cardiovascular disease, understanding t…
Large-consortium mechanistic research on how extreme heat events worsen outcomes in hypertensive patients, spanning cellular and molecular biology, thermoregulation, antihypertensive medication effects, and risk profiling.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Write proposalHow to Write a Grant Proposal Reviewers Can Score
Learn how to write a grant proposal around reviewer criteria, evidence, work packages, budget logic, and commercialization for deeptech and R&D funding.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
Write proposalGrant Concept Note Example: Pre-Proposal Structure for Startups
See a practical grant concept note example, with a worked deeptech pre-proposal, section map, invite-to-full logic, and reviewer checks.
More from NNF
All grants from this funder →Challenge Programme — AMR Diagnostics for LRTI
NNF · Denmark
Supports diagnostic innovations for antimicrobial resistant respiratory infections in Danish consortia.
Challenge Programme — Earth-Abundant Materials
NNF · Denmark
Supports interdisciplinary teams developing earth-abundant materials for climate and heavy industry technologies.
Challenge Programme — Hybrid Bio-Electrocatalysis
NNF · Denmark
Supports interdisciplinary teams exploring bioelectrocatalytic processes for sustainable materials and chemistry technologies.
Data Science Investigator Programme
🇩🇰NNF · Denmark
Supports Danish data science leaders in advanced computational and AI research.
Exploratory Interdisciplinary Synergy Programme
🇩🇰NNF · Denmark
Supports high-risk interdisciplinary research ideas before strong early-stage data exists.
Investigator Initiated Clinical Trials
🇩🇰NNF · Denmark
Supports Danish hospital teams with non-commercial clinical trials to improve patient care.
Similar grants
Browse the directory →
Qiantang Talent Program
🇨🇳Hangzhou HR & Social Security Bureau · China
Offers Hangzhou Qiantang pathways for life sciences, semiconductors, aerospace, and materials firms with housing and startup support.
Frontier Health and Medical Research
🇦🇺DoHDA · Australia
Funds breakthrough and frontier health and medical research with potential to transform health outcomes.
Mission Soil and Cancer: Living Labs for Carcinogenic Contamination
🇪🇺European Commission · European Union
Funds two €12M projects using living labs to remediate carcinogenic soils and trace cancer risks through people, food, water and air.
Horizon Health: Flavivirus Antibody Therapies
🇪🇺European Commission · European Union
Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one Flavivirus.
Pre-Commercial Procurement for Cancer Care
🇪🇺European Commission · European Union
Funds €8–10M procurer consortia to bring affordable cancer technologies, devices and medicines from tender to patient benefit.
Horizon Health: Antibody Therapies for Emerging Viruses
🇪🇺European Commission · European Union
Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one emerging virus.